Cyprus vs South-Eastern Asia: Proportion of the target population who received the final dose of
Cyprus
89.0%
in 2024
South-Eastern Asia
51.0%
in 2024
Cyprus rank
11th
South-Eastern Asia rank
13th
Proportion of the target population who received the final dose of over time
- Cyprus
- South-Eastern Asia
How they compare
Cyprus currently reports 89.0% against 51.0% in South-Eastern Asia, a difference of 38.0%.
That makes Cyprus's figure about 1.7 times South-Eastern Asia's.
Across all 7 years both countries report, Cyprus has been ahead every year.
Cyprus ranks 11th and South-Eastern Asia ranks 13th of 107 countries.
Cyprus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 61.7% | 8.3% | 53.3% | Cyprus |
| 2020s | 84.5% | 22.2% | 62.2% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Cyprus or South-Eastern Asia?
- Cyprus, at 89.0% against 51.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Cyprus and South-Eastern Asia?
- 38.0%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and South-Eastern Asia?
- 7 years are reported by both, from 2017 to 2024.
- How do Cyprus and South-Eastern Asia rank globally for proportion of the target population who received the final dose of?
- Cyprus ranks 11th and South-Eastern Asia ranks 13th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.